作为中国耐火性的辅助治疗,克罗巴萨姆的成本效益
Shunan Chen1,2, Fengqian Mao1,2, Yani Hu2
1School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, China.
International journal of clinical pharmacy
|November 30, 2024
概括
克洛巴萨姆 (CLB) 是一种成本效益高的辅助疗法,用于中国的耐火性. 这项研究发现,CLB提供了显著的质量调整寿命年 (QALYs) 以每QALY获得的可接受成本.
科学领域:
- 药物经济学 药物经济学
- 神经学 神经学
- 卫生技术评估 卫生技术评估
背景情况:
- 耐火性在中国是一个重大挑战.
- 克洛巴萨姆 (CLB) 是一种成熟的的辅助治疗方法.
- 在中国医疗保健系统中,CLB的成本效益还不清楚.
研究的目的:
- 评估Clobazam (CLB) 作为中国耐火性的辅助疗法的成本效益.
- 为了确定与传统治疗相比,CLB的增量成本效益比率 (ICER).
- 在中国医疗保健背景下评估CLB的经济价值.
主要方法:
- 一个终身马尔科夫模型模拟了患者的结果.
- 关于缓解率,效用和死亡率的数据来自临床试验和文献.
- 从中国一家医院收集了成本数据,并进行了敏感性分析.
主要成果:
- 辅助CLB治疗导致每QALY获得CNY1737.10的ICER,增量QALY为1.02.
- 每天的CLB剂量显著影响了ICER.
- 在WTP值为CNY 85698/QALY时,CLB的成本效益概率为77.35%.
结论:
- 克洛巴萨姆 (CLB) 是一种成本效益高的补充疗法,用于中国耐火性患者.
- 这些发现支持将CLB纳入中国人群中耐火性的治疗指南.
- CLB为治疗耐火性提供了一个有利的经济价值主张.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
146
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
146
Antiepileptic Drugs: GABAergic Pathway Potentiators
333
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
333
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
251
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
251
Antiepileptic Drugs: Calcium Channel Blockers
320
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
320
Antiepileptic Drugs: Glutamate Antagonists
283
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
283
Electroconvulsive Therapy
25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25


